federal_register: 00-2031
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 00-2031 | Determination of Regulatory Review Period for Purposes of Patent Extension; CertivaTM | Uncategorized Document | The Food and Drug Administration (FDA) has determined the regulatory review period for Certiva<SUP>TM</SUP> and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of an application to the Commissioner of Patents and Trademarks, Department of Commerce, for the extension of a patent which claims that human biological product. | 2000-01-31 | 2000 | 1 | https://www.federalregister.gov/documents/2000/01/31/00-2031/determination-of-regulatory-review-period-for-purposes-of-patent-extension-certivatm | https://www.govinfo.gov/content/pkg/FR-2000-01-31/pdf/00-2031.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA) has determined the regulatory review period for Certiva<SUP>TM</SUP> and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of an... |